380
Views
69
CrossRef citations to date
0
Altmetric
Review

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

, , , , , , , , , & show all
Pages 593-602 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Matthew A. Meissner, Barrett Z. McCormick, Jose A. Karam & Christopher G. Wood. (2018) Adjuvant therapy for advanced renal cell carcinoma. Expert Review of Anticancer Therapy 18:7, pages 663-671.
Read now
Rumiko Shimazawa & Masayuki Ikeda. (2015) International differences in companion diagnostic approvals: how are we able to manage the differences?. Expert Review of Molecular Diagnostics 15:2, pages 157-159.
Read now
Brett Doble, Marcus Tan, Anthony Harris & Paula Lorgelly. (2015) Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist. Expert Review of Molecular Diagnostics 15:2, pages 235-254.
Read now
Jiezhong Chen, Renfu Shao, Xu Dong Zhang & Chen Chen. (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8, pages 2677-2688.
Read now
Holger Heyn, Jesús Méndez-González & Manel Esteller. (2013) Epigenetic profiling joins personalized cancer medicine. Expert Review of Molecular Diagnostics 13:5, pages 473-479.
Read now

Articles from other publishers (64)

Javier Martín-López, Federico Rojo, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucía Ruiz de Alda, J Francisco García & Clara Salas. (2023) Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of Clinical Pathology 76:5, pages 327-332.
Crossref
Saumya Srivastava & Anjana Pandey. 2023. Oncology: Genomics, Precision Medicine and Therapeutic Targets. Oncology: Genomics, Precision Medicine and Therapeutic Targets 1 24 .
Clara Salas, Javier Martín-López, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucia Ruiz de Alda, J Francisco García & Federico Rojo. (2022) Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of Clinical Pathology 75:3, pages 193-200.
Crossref
Alexander Zarbock. (2021) The Journey Begins: Personalized Acute Kidney Injury Therapy*. Critical Care Medicine 49:10, pages 1822-1825.
Crossref
Yingxin Kan, Limin Jiang, Jijun Tang, Yan Guo & Fei Guo. (2021) A systematic view of computational methods for identifying driver genes based on somatic mutation data. Briefings in Functional Genomics 20:5, pages 333-343.
Crossref
Tianxi Cai, T. Tony Cai & Zijian Guo. (2021) Optimal Statistical Inference for Individualized Treatment Effects in High-Dimensional Models. Journal of the Royal Statistical Society Series B: Statistical Methodology 83:4, pages 669-719.
Crossref
Hariharan Moorthy & Thimmaiah Govindaraju. (2021) Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Applied Bio Materials 4:2, pages 1115-1139.
Crossref
Marios Spanakis, Athina E. Patelarou & Evridiki Patelarou. (2020) Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice. Journal of Personalized Medicine 10:3, pages 56.
Crossref
Narges Aberuyi, Soheila Rahgozar, Elaheh Sadat Ghodousi & Kamran Ghaedi. (2020) Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Saima Shakil Malik, Iqra, Nosheen Akhtar, Iffat Fatima, Zaineb Akram & Nosheen Masood. 2020. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine 313 332 .
Allen D. Everett, Shama S. Alam, Sherry L. Owens, Devin M. Parker, Christine Goodrich, Donald S. Likosky, Heather Thiessen-Philbrook, Moritz Wyler von Ballmoos, Kevin Lobdell, Todd A. MacKenzie, Jeffrey Jacobs, Chirag R. Parikh, Anthony W. DiScipio, David J. Malenka & Jeremiah R. Brown. (2019) The Association between Cytokines and 365-Day Readmission or Mortality in Adult Cardiac Surgery. The Journal of ExtraCorporeal Technology 51:4, pages 201-209.
Crossref
Marta Molina Romero, Emilio José Laserna Mendieta, Gema María Varo Sánchez, María Concepción Alonso-Cerezo & María Orera Clemente. (2019) Oncología personalizada: principales biomarcadores en el pronóstico y tratamiento de tumores sólidos. Revista del Laboratorio Clínico 12:3, pages e1-e8.
Crossref
Rafael Selbach Scheffel & Ana Luiza Maia. (2019) The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer. Archives of Endocrinology and Metabolism 63:2, pages 95-96.
Crossref
Wendy Yang & Michael F. Berger. 2019. Precision Cancer Medicine. Precision Cancer Medicine 5 31 .
Mohammad Al-Kaiyat. (2018) Precision Coordination: The Growing Role of the Nurse Coordinator in the Era of Personalized Medicine
. Clinical Journal of Oncology Nursing 22:1, pages 113-115.
Crossref
. 2018. Diagnostic Pathology: Cytopathology. Diagnostic Pathology: Cytopathology 730 733 .
L. V. K. S. Bhaskar & L. Saikrishna. 2018. Role of Tyrosine Kinases in Gastrointestinal Malignancies. Role of Tyrosine Kinases in Gastrointestinal Malignancies 191 224 .
Yongkuan Cao, Guohu Zhang, Peihong Wang, Jun Zhou, Wei Gan, Yaning Song, Ling Huang, Ya Zhang, Guode Luo, Jiaqing Gong & Lin Zhang. (2017) Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. BMC Gastroenterology 17:1.
Crossref
Sally Safwat, Rania A Ishak, Rania M Hathout & Nahed D Mortada. (2017) Statins anticancer targeted delivery systems: re-purposing an old molecule. Journal of Pharmacy and Pharmacology 69:6, pages 613-624.
Crossref
Brett Doble, Thomas John, David Thomas, Andrew Fellowes, Stephen Fox & Paula Lorgelly. (2017) Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing. Lung Cancer 107, pages 22-35.
Crossref
Marcin Opławski, Mateusz Michalski, Andrzej Witek, Bogdan Michalski, Nikola Zmarzły, Agnieszka Jęda-Golonka, Maria Styblińska, Joanna Gola, Małgorzata Kasprzyk-Żyszczyńska, Urszula Mazurek & Andrzej Plewka. (2017) Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer. Molecular Medicine Reports 16:3, pages 2547-2555.
Crossref
Yuanyuan ShenTianxi Cai. (2016) Identifying predictive markers for personalized treatment selection. Biometrics 72:4, pages 1017-1025.
Crossref
Xue Qiu, K. David Wegner, Yu-Tang Wu, Paul M. P. van Bergen en Henegouwen, Travis L. Jennings & Niko Hildebrandt. (2016) Nanobodies and Antibodies for Duplexed EGFR/HER2 Immunoassays Using Terbium-to-Quantum Dot FRET. Chemistry of Materials 28:22, pages 8256-8267.
Crossref
Hyo Sook Han & Anthony M. Magliocco. (2016) Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer. Clinical Breast Cancer 16:3, pages 166-179.
Crossref
Jin-hui Liu, Pei Xi, Yan-lan Chai, Juan Wang, Tao Wang, Zi Liu & Peng-gao Dai. (2016) Association of DNA repair gene polymorphisms with response to cisplatin-based concurrent chemoradiotherapy in patients with cervical carcinoma. DNA Repair 41, pages 69-72.
Crossref
AnXiu Gao, YunLi Tian, ZhuanZhuan Shi & Ling Yu. (2015) A cost-effective microdevice bridges microfluidic and conventional in vitro scratch / wound-healing assay for personalized therapy validation. BioChip Journal 10:1, pages 56-64.
Crossref
Mahendran Botlagunta. 2016. Nutraceuticals. Nutraceuticals 783 839 .
Urszula Demkow. 2016. Clinical Applications for Next-Generation Sequencing. Clinical Applications for Next-Generation Sequencing 217 240 .
Dinko Vitezić, Nada Božina, Jasenka Mršić-Pelčić, Viktorija Erdeljić Turk & Igor Francetić. 2016. Personalized Medicine. Personalized Medicine 265 278 .
Qing Liu, Swee Yin Lim, Ross A. Soo, Mi Kyoung Park & Yong Shin. (2015) A rapid MZI-IDA sensor system for EGFR mutation testing in non-small cell lung cancer (NSCLC). Biosensors and Bioelectronics 74, pages 865-871.
Crossref
S. Scarano, S. Mariani & M. Minunni. 2015. Advanced Bioelectronic Materials. Advanced Bioelectronic Materials 55 88 .
Daniela Sia, Agrin Moeini, Ismail Labgaa & Augusto Villanueva. (2015) The future of patient-derived tumor xenografts in cancer treatment. Pharmacogenomics 16:14, pages 1671-1683.
Crossref
Thomas K. Karikari, Emmanuel Quansah & Wael M.Y. Mohamed. (2015) Widening participation would be key in enhancing bioinformatics and genomics research in Africa. Applied & Translational Genomics 6, pages 35-41.
Crossref
SHUN-ICHI SUZUKI, SATOSHI MATSUSAKA, MITSUHARU HIRAI, HARUMI SHIBATA, KOICHI TAKAGI, NOBUYUKI MIZUNUMA & KIYOHIKO HATAKE. (2015) A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction. International Journal of Oncology 47:1, pages 97-105.
Crossref
Marilyn Tsourounis, Jeffrey Stuart, William Pignato, Michael Toscani & Joseph Barone. (2015) Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics. Therapeutic Innovation & Regulatory Science 49:4, pages 530-543.
Crossref
Katherine M Keyes, George Davey Smith, Karestan C Koenen & Sandro Galea. (2015) The mathematical limits of genetic prediction for complex chronic disease. Journal of Epidemiology and Community Health 69:6, pages 574-579.
Crossref
Juan Wang, Yan-lan Chai, Tao Wang, Jin-hui Liu, Peng-gao Dai & Zi Liu. (2015) Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy. Experimental and Molecular Pathology 98:3, pages 407-410.
Crossref
Kunitoshi Shigeyasu, Hiroshi Tazawa, Yuuri Hashimoto, Yoshiko Mori, Masahiko Nishizaki, Hiroyuki Kishimoto, Takeshi Nagasaka, Shinji Kuroda, Yasuo Urata, Ajay Goel, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2015) Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics. Gut 64:4, pages 627-635.
Crossref
Mei Haruya & Shingo Kano. (2015) A new look at the corporate capability of personalized medicine development in the pharmaceutical industry. R&D Management 45:1, pages 94-103.
Crossref
Takeki Uehara, Yuping Wang & Weida Tong. 2015. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 75 109 .
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2015. Biomarkers in Cancer. Biomarkers in Cancer 325 344 .
Carleton T. Garrett. 2015. Molecular Oncology Testing for Solid Tumors. Molecular Oncology Testing for Solid Tumors 3 65 .
Taofic Mounajjed, Char L. Brown, Therese K. Stern, Annette M. Bjorheim, Andrew J. Bridgeman, Kandelaria M. Rumilla, Robert R. McWilliams & Thomas J. Flotte. (2014) Preappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicine. Human Pathology 45:11, pages 2240-2246.
Crossref
Jeffrey Tobias & Daniel Hochhauser. 2014. Cancer and its Management. Cancer and its Management 81 112 .
João Renato Rebello Pinho, Roberta Sitnik & Cristóvão Luis Pitangueira Mangueira. (2014) Personalized medicine and the clinical laboratory. Einstein (São Paulo) 12:3, pages 366-373.
Crossref
Laura Wayteck, Karine Breckpot, Jo Demeester, Stefaan C. De Smedt & Koen Raemdonck. (2014) A personalized view on cancer immunotherapy. Cancer Letters 352:1, pages 113-125.
Crossref
Henrica M. J. Werner, Jone Trovik, Mari K. Halle, Elisabeth Wik, Lars A. Akslen, Even Birkeland, Therese Bredholt, Ingvild L. Tangen, Camilla Krakstad & Helga B. Salvesen. (2014) Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer. PLoS ONE 9:2, pages e90141.
Crossref
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly & Omid C. Farokhzad. (2014) Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews 66, pages 2-25.
Crossref
D.C. Anderson & Krishna Kodukula. (2014) Biomarkers in pharmacology and drug discovery. Biochemical Pharmacology 87:1, pages 172-188.
Crossref
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2014. Biomarkers in Cancer. Biomarkers in Cancer 1 16 .
Takeki Uehara, Yuping Wang & Weida Tong. 2014. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 1 25 .
Richard A. Scolyer, Klaus J. Busam & Raymond L. Barnhill. 2014. Pathology of Melanocytic Nevi and Melanoma. Pathology of Melanocytic Nevi and Melanoma 529 567 .
Soya S. Sam & Gregory J. Tsongalis. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer 405 421 .
Kitchener D. Wilson & Iris Schrijver. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer 3 13 .
Xia Pu, Yuanqing Ye & Xifeng Wu. (2014) Development and validation of risk models and molecular diagnostics to permit personalized management of cancer. Cancer 120:1, pages 11-19.
Crossref
L. Fashoyin-Aje, K. Sanghavi, K. Bjornard & J. Bodurtha. (2013) Integrating genetic and genomic information into effective cancer care in diverse populations. Annals of Oncology 24, pages vii48-vii54.
Crossref
Hiroaki Nitta, Koji Tsuta, Akihiko Yoshida, Steffan N. Ho, Brian D. Kelly, Lauren B. Murata, Jerry Kosmeder, Katie White, Sandra Ehser, Penny Towne, Crystal Schemp, Abigail McElhinny, Jim Ranger-Moore, Chris Bieniarz, Shalini Singh, Hitoshi Tsuda & Thomas M. Grogan. (2013) New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay. Journal of Thoracic Oncology 8:8, pages 1019-1031.
Crossref
Jeanette J. McCarthyHoward L. McLeodGeoffrey S. Ginsburg. (2013) Genomic Medicine: A Decade of Successes, Challenges, and Opportunities. Science Translational Medicine 5:189.
Crossref
Howard I. Scher, Michael J. Morris, Steven Larson & Glenn Heller. (2013) Validation and clinical utility of prostate cancer biomarkers. Nature Reviews Clinical Oncology 10:4, pages 225-234.
Crossref
Frank Ong, Jane Kuo, Wei-Chi Wu, Ching-Yu Cheng, Wendell-Lamar Blackwell, Brian Taylor, Wayne Grody, Jerome Rotter, Chi-Chun Lai & Tien Wong. (2013) Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. Journal of Personalized Medicine 3:1, pages 40-69.
Crossref
John B. McIntyre, Jackson S. Wu, Peter S. Craighead, Tien Phan, Martin Köbel, Susan P. Lees-Miller, Prafull Ghatage, Anthony M. Magliocco & Corinne M. Doll. (2013) PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy. Gynecologic Oncology 128:3, pages 409-414.
Crossref
Jennifer L. Harris, Michael Stocum, Lisa Roberts, Chunsheng Jiang, Jessie Lin & Kam Sprott. (2013) Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells. Drug Development Research 74:2, pages 138-147.
Crossref
S. Souchelnytskyi. (2013) INDIVIDUALIZATION OF CANCER TREATMENT: CONTRIBUTION OF OMICS TECHNOLOGIES TO CANCER DIAGNOSTIC. Biotechnologia Acta 6:4, pages 105-117.
Crossref
Guang Hu, Yuqian Li & Bairong Shen. 2013. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases 189 205 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.